Suven grants exclusive license to Taro Pharmaceuticals
Taro will pay Suven a royalty
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Jubilant Life Sciences resolution for Montreal facility
Jubilant Life Sciences has received a communication from the US Food and Drug Administration (US FDA), classifying its…
Biomarker discovery presents opportunities for players in Parkinson’s Disease market:…
GlobalData predicts PD prevalence to increase from 2.5 million patients to 3.2 million across the seven major markets
Lupin receives approval for acne treatment
Lupin has received final approval for its Doxycycline capsules USP, 50 mg, 75 mg, and 100 mg from the United States Food and Drugs…
Claris Lifesciences posts consolidated revenues at Rs 7,084 million
EBITDA margin reported at Rs 2,100 million
Strand receives US patent for virtual liver model
Announces release of the human version of the virtual liver model
GSK increases stake in local pharma subsidiary to 75 per cent after open offer
GlaxoSmithKline accepts 20,609,774 shares of GlaxoSmithKline Pharmaceuticals
Focus on speciality pharma drives M&A activity in Feb 2014
Indian pharma sector witnesses no deals during February 2014
IPC-IMA TNSB Pharmacovigilance CME held at Chennai
Saw participation of 75 clinicians and pharmacologists
IPA-MSB, IPA-CPD organises training programme for pharmacists
The programme had a mix of lectures, interaction, demonstrations and panel discussions